Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Heart Failure Clinics|December 1, 2009
Targeting heart failure therapeutics: a historical perspectiveGuinevere A Murphy, Mona Fiuzat, Michael R BristowJournal of Molecular Biology|November 26, 2003
The Sir4 C-terminal coiled coil is required for telomeric and mating type silencing in Saccharomyces cerevisiaeGuinevere A Murphy, Erik J Spedale, Sean T Powell, et al.Proceedings of the National Academy of Sciences of the United States of America|April 2, 2010
Crystal structure of HLA-DP2 and implications for chronic beryllium diseaseShaodong Dai, Guinevere A Murphy, Frances Crawford, et al.JACC. Heart Failure|October 26, 2013
Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphismRyan G Aleong, William H Sauer, Gordon Davis, et al.European Journal of Heart Failure|December 11, 2012
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillationDavid P Kao, Gordon Davis, Ryan Aleong, et al.Circulation. Heart Failure|November 3, 2009
An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failureMichael R Bristow, Guinevere A Murphy, Heidi Krause-Steinrauf, et al.Plos One|October 17, 2012
Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphismsChristopher M O'Connor, Mona Fiuzat, Peter E Carson, et al.Pageof 1